|
MediciNova Receives a Notice of European Patent Allowance for Treating …
NASDAQ MediciNova's pipeline includes six clinical-stage compounds for the treatment of acute exacerbations of asthma, chronic obstructive pulmonary disease exacerbations, multiple sclerosis and other neurologic conditions, asthma, interstitial cystitis … MediciNova Receives Notice of European Patent Allowance for Treating … |
View full post on asthma – Google News